Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25
Closed -$2.78K 2121
2026
Q1
$2.78K Sell
25
-1
-4% -$118 ﹤0.01% 3792
2025
Q4
$3.51K Buy
26
+10
+63% +$1.09K ﹤0.01% 3248
2025
Q3
$1.36K Buy
+16
New +$981 ﹤0.01% 3409

Other funds holding ABVX

MAI Capital Management's ABVX Position: Q2 2026 in Review

MAI Capital Management sold out of Abivax (ABVX) in Q2 2026, closing a stake of 25 shares — an estimated $2.78K sold.

MAI Capital Management first reported a position in ABVX in Q3 2025 and held it in 3 quarters. The position peaked at $3.51K in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • MAI Capital Management reported no remaining Abivax position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 25 Abivax shares in Q2 2026, an estimated $2.78K.
  • MAI Capital Management first reported a position in Abivax in Q3 2025 and held it in 3 quarters.
  • MAI Capital Management's Abivax position peaked at $3.51K in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.